Omni Bio Pharmaceutical Inc OMBP:OTCBB - OTC Pink Current Information (Common Stock)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
0.19 -0.02   -9.52% 35,4866.8K
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for Omni Bio Pharmaceutical Inc

No News for Omni Bio Pharmaceutical Inc

Latest Annual and Quarterly SEC Filings

More Filings
10-K

This report contains detailed information about the company's business finances and management.

10-Q

Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)

Company Background

Omni Bio Pharmaceutical, Inc. (Omni Bio) is a development-stage company. The Company is a biopharmaceutical company that was initially formed to explore new methods of use of Alpha-1 antitrypsin (AAT), also referred to as plasma-derived AAT. The Company holds a license to an issued method of use patent for the treatment of diabetes using p-AAT with a privately-held company, Bio Holding, Inc. In addition, it holds licenses with the Regents of the University of Colorado (RUC) for method of use patents and patent applications (Use Patents) covering the use of p-AAT in the indications: cellular transplantation and graft rejection, radiation protection, certain bacterial and viral diseases, myocardial remodeling and inflammatory bowel disease. It also hold licenses with RUC for patent applications covering composition of matter for various Fc-AAT constructs.

http://www.omnibiopharma.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open0.19
Previous Close0.19
Day High--
Day Low--
52 Week High1/24/2014 | 0.50
52 Week Low10/11/2013 | 0.1201
% Off 52 Week High-62.00%
% Off 52 Week Low58.20%
Beta (5 Yr)-0.23
Volatility Avg10/8/2014 | 210.18
10-Day Avg. Volume6,763
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | -0.07
P/E Ratio6/30/2014 | --
Market CapMicro Cap | 7M
Shares Outstanding38.86M
Float23.5M

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield--
Ex-Date--
Dividend Announcement--
Date of Record--
Payable-- - --
Payable Date--

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short--
Short Ratio--
Short % of Float--
As of --

Peers Information HelpOMBP Omni Bio Pharmaceutical Inc vs. Peers

Peers 
OMBP
Omni Bio Pharmaceutical Inc
-50.48%
Johnson & Johnson
14.54%
Merck & Co., Inc.
20.24%
Amgen, Inc.
22.78%
Gilead Sciences, Inc.
44.97%
OMBP
Omni Bio Pharmaceutical Inc
0.00%
Johnson & Johnson
2.67%
Merck & Co., Inc.
2.92%
Amgen, Inc.
1.74%
Gilead Sciences, Inc.
--
OMBP
Omni Bio Pharmaceutical Inc
-9.52%
Johnson & Johnson
2.46%
Merck & Co., Inc.
2.94%
Amgen, Inc.
2.97%
Gilead Sciences, Inc.
-100.00%
Compare these stocks